back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-30 10:31 Tx date 2023-03-08 |
$KHRN
Khiron Life Sciences Corp. |
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,705
+238,000 vol $0.0912 each |
12,296,429 | |
| Filed 2024-04-30 10:30 Tx date 2023-02-28 |
$KHRN
Khiron Life Sciences Corp. |
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+12,000 vol $0.10 each |
12,058,429 | |
| Filed 2022-09-06 17:10 Tx date 2022-09-06 |
$KHRN
Khiron Life Sciences Corp. |
Echeverry, Juan Carlos
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-120,000 vol |
0 | |
| Filed 2022-06-14 13:02 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+1,000,000 vol |
1,000,000 | |
| Filed 2022-06-14 13:01 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+1,000,000 vol $0.15 each |
1,716,500 | |
| Filed 2022-06-14 12:58 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+400,000 vol |
400,000 | |
| Filed 2022-06-14 12:58 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:58 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,000
+400,000 vol $0.15 each |
400,000 | |
| Filed 2022-06-14 12:57 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+100,000 vol |
100,000 | |
| Filed 2022-06-14 12:53 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$15,000
+100,000 vol $0.15 each |
258,900 | |
| Filed 2022-06-14 12:46 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+400,000 vol |
400,000 | |
| Filed 2022-06-14 12:46 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:45 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,000
+400,000 vol $0.15 each |
1,305,000 | |
| Filed 2022-06-13 19:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
$27,000
+135,000 vol $0.20 each |
135,000 | |
| Filed 2022-06-13 19:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,250
+135,000 vol $0.15 each |
135,000 | |
| Filed 2022-06-13 19:52 Tx date 2021-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-13 19:52 Tx date 2021-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-13 19:18 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$27,000
+135,000 vol $0.20 each |
||
| Filed 2022-06-13 19:17 Tx date 2021-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-13 19:17 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,250
+135,000 vol $0.15 each |
||
| Filed 2022-06-13 19:16 Tx date 2021-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-04 16:58 Tx date 2022-01-04 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,030
+50,000 vol $0.2406 each |
1,405,000 | |
| Filed 2021-12-23 18:37 Tx date 2021-12-23 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,250
+150,000 vol $0.215 each |
1,355,000 | |
| Filed 2021-12-22 17:08 Tx date 2021-12-22 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,200
+240,000 vol $0.205 each |
905,000 | |
| Filed 2021-12-03 13:24 Tx date 2021-12-03 |
$KHRN
Khiron Life Sciences Corp. |
Echeverry, Juan Carlos
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,000
+120,000 vol $0.20 each |
120,000 | |
| Filed 2021-12-03 13:24 Tx date 2020-11-30 |
$KHRN
Khiron Life Sciences Corp. |
Echeverry, Juan Carlos
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-25 15:36 Tx date 2021-11-23 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+600,000 vol |
1,200,000 | |
| Filed 2021-11-25 15:34 Tx date 2021-11-23 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,400,000 vol |
1,600,000 | |
| Filed 2021-11-25 15:28 Tx date 2021-11-23 |
$KHRN
Khiron Life Sciences Corp. |
Guarin Perez, Carlos Andres
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2021-11-25 15:26 Tx date 2021-06-30 |
$KHRN
Khiron Life Sciences Corp. |
Guarin Perez, Carlos Andres
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-23 19:28 Tx date 2021-11-23 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2021-11-23 19:27 Tx date 2021-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-13 18:51 Tx date 2021-09-13 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,900
+50,000 vol $0.298 each |
665,000 | |
| Filed 2021-06-04 16:37 Tx date 2021-06-03 |
$KHRN
Khiron Life Sciences Corp. |
Alvarez, Juan Diego
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-71,114.40
-153,000 vol $0.4648 each |
154,500 | |
| Filed 2021-06-04 16:36 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Alvarez, Juan Diego
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$-6,975
-15,000 vol $0.465 each |
307,500 | |
| Filed 2021-06-03 17:55 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Navarro, Elsa
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+59,000 vol |
209,000 | |
| Filed 2021-06-03 17:50 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
2,000,000 | |
| Filed 2021-06-03 17:49 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$250,000,000,000
+500,000 vol $500,000 each |
||
| Filed 2021-06-03 17:41 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$250,000,000,000
+500,000 vol $500,000 each |
||
| Filed 2021-06-03 17:40 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
0 | |
| Filed 2021-06-03 17:32 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Duran, Rodrigo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+85,000 vol |
235,000 | |
| Filed 2021-06-03 17:28 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Buendia, Manuel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+75,000 vol |
387,500 | |
| Filed 2021-06-03 17:24 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Alvarez, Juan Diego
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+70,500 vol |
893,000 | |
| Filed 2021-06-03 17:17 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,400,000 vol |
2,200,000 | |
| Filed 2021-06-03 17:15 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+600,000 vol |
1,400,000 | |
| Filed 2021-06-03 17:10 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,400,000 vol |
2,200,000 | |
| Filed 2021-06-03 17:06 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+600,000 vol |
1,400,000 | |
| Filed 2021-02-10 14:31 Tx date 2021-02-09 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+5,000 vol $0.58 each |
615,000 | |
| Filed 2021-02-10 14:26 Tx date 2021-02-08 |
$KHRN
Khiron Life Sciences Corp. |
Friedman, Joel David
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$117,500
+250,000 vol $0.47 each |
350,000 | |
| Filed 2021-02-10 14:17 Tx date 2021-02-08 |
$KHRN
Khiron Life Sciences Corp. |
Rosati, Deborah
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$100,000
+212,766 vol $0.47 each |
612,766 | |
| Filed 2021-02-10 14:10 Tx date 2021-02-08 |
$KHRN
Khiron Life Sciences Corp. |
Echeverry, Juan Carlos
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$200,000
+425,532 vol $0.47 each |
425,532 | |
| Filed 2021-02-10 14:07 Tx date 2020-11-30 |
$KHRN
Khiron Life Sciences Corp. |
Echeverry, Juan Carlos
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-21 17:11 Tx date 2020-12-16 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
1,500,000 | |
| Filed 2020-12-21 17:05 Tx date 2020-12-16 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
500,000 | |
| Filed 2020-12-11 15:17 Tx date 2020-12-10 |
$KHRN
Khiron Life Sciences Corp. |
Rosati, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,775
+25,000 vol $0.391 each |
67,000 | |
| Filed 2020-12-11 15:16 Tx date 2020-12-09 |
$KHRN
Khiron Life Sciences Corp. |
Rosati, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,750
+25,000 vol $0.39 each |
42,000 | |
| Filed 2020-12-11 15:12 Tx date 2020-12-11 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,740
+20,000 vol $0.387 each |
1,205,000 | |
| Filed 2020-12-08 14:31 Tx date 2020-12-04 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+20,000 vol $0.40 each |
20,000 | |
| Filed 2020-12-08 14:29 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-04 13:57 Tx date 2020-12-04 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+50,000 vol $0.40 each |
1,185,000 | |
| Filed 2020-12-03 12:35 Tx date 2020-12-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Warrants
10 - Acquisition or disposition in the public market
|
$7,815
+75,000 vol $0.1042 each |
75,000 | |
| Filed 2020-12-03 12:04 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-03 15:40 Tx date 2020-10-26 |
$KHRN
Khiron Life Sciences Corp. |
Friedman, Joel David
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2020-09-18 19:05 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Buendia, Manuel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
37,500 | ||
| Filed 2020-09-18 19:02 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Buendia, Manuel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2020-09-18 18:54 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Buendia, Manuel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
312,500 | ||
| Filed 2020-09-18 18:44 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Gasi, Rayet Harb
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2020-09-18 18:27 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Navarro, Elsa
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2020-09-18 14:30 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Duran, Rodrigo
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2020-09-18 13:40 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Alvarez, Juan Diego
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
822,500 | ||
| Filed 2020-09-18 13:22 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Alvarez, Juan Diego
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
322,500 | ||
| Filed 2020-09-14 10:32 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Rosati, Deborah
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+400,000 vol |
400,000 | |
| Filed 2020-09-14 10:30 Tx date 2019-11-04 |
$KHRN
Khiron Life Sciences Corp. |
Rosati, Deborah
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 10:28 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2020-09-14 10:22 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
100,000 | |
| Filed 2020-09-14 10:20 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 10:18 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+400,000 vol |
400,000 | |
| Filed 2020-09-14 10:10 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-04 16:39 Tx date 2020-09-04 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,750
+75,000 vol $0.53 each |
1,135,000 | |
| Filed 2020-09-04 16:30 Tx date 2020-09-04 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,200
+10,000 vol $0.52 each |
610,000 | |
| Filed 2020-08-31 14:04 Tx date 2020-08-26 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+600,000 vol |
600,000 | |
| Filed 2020-06-02 15:07 Tx date 2020-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,225,000
+500,000 vol $2.45 each |
1,000,000 | |
| Filed 2020-06-02 15:04 Tx date 2020-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,225,000
-500,000 vol $2.45 each |
1,000,000 | |
| Filed 2020-06-02 14:30 Tx date 2020-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,250
+25,000 vol $2.45 each |
950,000 | |
| Filed 2020-06-02 14:25 Tx date 2020-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-61,250
-25,000 vol $2.45 each |
50,000 | |
| Filed 2020-05-25 15:42 Tx date 2020-05-23 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,375
+37,500 vol $0.89 each |
158,900 | |
| Filed 2020-05-25 15:41 Tx date 2020-05-23 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
0 | |
| Filed 2020-05-25 15:36 Tx date 2020-05-23 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$122,375
+137,500 vol $0.89 each |
600,000 | |
| Filed 2020-05-25 15:34 Tx date 2020-05-23 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-137,500 vol |
0 | |
| Filed 2020-04-13 17:47 Tx date 2020-03-19 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,200
-150,000 vol $0.368 each |
693,500 | |
| Filed 2020-04-13 17:46 Tx date 2020-03-18 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-49,822.50
-136,500 vol $0.365 each |
843,500 | |
| Filed 2020-04-13 17:45 Tx date 2020-03-16 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,950
-50,000 vol $0.399 each |
980,000 | |
| Filed 2020-04-13 17:43 Tx date 2020-03-13 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-122,745
-245,000 vol $0.50 each |
1,030,000 | |
| Filed 2020-02-21 10:42 Tx date 2020-02-19 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,200
+5,000 vol $0.64 each |
462,500 | |
| Filed 2020-02-14 10:37 Tx date 2020-02-14 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,000
+50,000 vol $0.64 each |
716,500 | |
| Filed 2020-02-13 11:51 Tx date 2020-02-13 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+5,000 vol $0.65 each |
457,500 | |
| Filed 2020-02-07 17:19 Tx date 2020-02-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,945
+28,500 vol $0.77 each |
666,500 | |
| Filed 2020-02-07 17:19 Tx date 2020-02-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,100
+70,000 vol $0.73 each |
638,000 | |
| Filed 2020-02-06 11:41 Tx date 2020-02-05 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+5,000 vol $0.80 each |
452,500 | |
| Filed 2020-02-03 10:14 Tx date 2020-01-19 |
$KHRN
Khiron Life Sciences Corp. |
Perez Silveira, Maximiliano
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-95,040
-99,000 vol $0.96 each |
250,641 | |
| Filed 2020-01-07 15:59 Tx date 2019-12-31 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,300
+15,000 vol $1.02 each |
447,500 | |
| Filed 2019-12-17 12:35 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,375
+37,500 vol $0.89 each |
121,400 | |
| Filed 2019-12-17 12:33 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
37,500 | |
| Filed 2019-12-17 12:31 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$66,750
+75,000 vol $0.89 each |
75,000 | |
| Filed 2019-12-17 12:30 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-75,000 vol |
75,000 | |
| Filed 2019-12-17 12:27 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$122,375
+137,500 vol $0.89 each |
432,500 | |
| Filed 2019-12-17 12:25 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-137,500 vol |
137,500 | |
| Filed 2019-12-17 12:22 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$244,750
+275,000 vol $0.89 each |
275,000 | |
| Filed 2019-12-17 12:21 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-275,000 vol |
275,000 | |
| Filed 2019-12-10 20:58 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,406,250,000
+37,500 vol $37,500 each |
||
| Filed 2019-12-10 20:55 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
||
| Filed 2019-12-10 16:51 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+137,500 vol |
||
| Filed 2019-12-10 16:49 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-137,500 vol |
||
| Filed 2019-12-16 16:09 Tx date 2019-12-13 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,650
+5,000 vol $0.93 each |
1,060,000 | |
| Filed 2019-12-16 16:08 Tx date 2019-12-11 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,600
+5,000 vol $0.92 each |
1,055,000 | |
| Filed 2019-12-11 11:02 Tx date 2019-12-06 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,250
+25,000 vol $2.45 each |
925,000 | |
| Filed 2019-12-11 11:00 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
900,000 | ||
| Filed 2019-12-11 10:56 Tx date 2019-12-06 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-25,000 vol |
75,000 | |
| Filed 2019-12-11 10:47 Tx date 2019-12-06 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,225,000
+500,000 vol $2.45 each |
500,000 | |
| Filed 2019-12-11 10:41 Tx date 2018-07-17 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-11 10:38 Tx date 2019-12-06 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
1,500,000 | |
| Filed 2019-12-10 21:10 Tx date 2019-12-06 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,250
+25,000 vol $2.45 each |
1,275,000 | |
| Filed 2019-12-10 21:08 Tx date 2019-12-06 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-25,000 vol |
75,000 | |
| Filed 2019-12-10 20:58 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,406,250,000
+37,500 vol $37,500 each |
46,400 | |
| Filed 2019-12-10 20:55 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
112,500 | |
| Filed 2019-12-10 20:53 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2019-12-10 16:51 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+137,500 vol |
157,500 | |
| Filed 2019-12-10 16:49 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-137,500 vol |
412,500 | |
| Filed 2019-12-10 16:37 Tx date 2018-05-23 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+550,000 vol |
550,000 | |
| Filed 2019-12-10 16:24 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-29 14:49 Tx date 2019-11-27 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
800,000 | |
| Filed 2019-11-29 14:47 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-29 14:47 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+800,000 vol |
800,000 | |
| Filed 2019-11-29 14:46 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-29 14:43 Tx date 2019-11-27 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
800,000 | |
| Filed 2019-11-29 14:40 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-29 14:40 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+800,000 vol |
800,000 | |
| Filed 2019-11-29 14:38 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-12 16:26 Tx date 2019-11-04 |
$KHRN
Khiron Life Sciences Corp. |
Rosati, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
17,000 | ||
| Filed 2019-08-30 12:25 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+1,000 vol $1.40 each |
1,000 | |
| Filed 2019-08-30 12:24 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-30 12:17 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,905
+8,900 vol $1.45 each |
8,900 | |
| Filed 2019-08-30 12:15 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-30 12:10 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,200
+20,000 vol $1.41 each |
20,000 | |
| Filed 2019-08-30 12:07 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-30 12:04 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,600
+10,000 vol $1.56 each |
1,050,000 | |
| Filed 2019-08-30 12:04 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,800
+10,000 vol $1.48 each |
1,040,000 | |
| Filed 2019-08-30 12:01 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,200
+10,000 vol $1.42 each |
1,030,000 | |
| Filed 2019-08-27 13:02 Tx date 2019-08-23 |
$KHRN
Khiron Life Sciences Corp. |
Kaufman, Wendy
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+300,000 vol |
300,000 | |
| Filed 2019-08-27 12:56 Tx date 2019-07-02 |
$KHRN
Khiron Life Sciences Corp. |
Kaufman, Wendy
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-29 16:39 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,000,000 vol |
2,000,000 | |
| Filed 2019-07-29 16:34 Tx date 2018-07-17 |
$KHRN
Khiron Life Sciences Corp. |
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-26 14:54 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+400,000 vol |
400,000 | |
| Filed 2019-07-26 14:46 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-12 12:54 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Graciela Martinelli (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,325 | ||
| Filed 2019-06-26 22:05 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2019-06-26 21:56 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Silveira, Maximiliano Perez
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
349,641 | ||
| Filed 2019-06-26 21:54 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Silveira, Maximiliano Perez
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2019-06-26 21:33 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Beramendi, Marco Algorta
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2019-06-26 21:30 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Beramendi, Marco Algorta
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
495,397 | ||
| Filed 2019-06-26 17:14 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Loinaz D'Isabella, Agustina Nathalia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
495,397 | ||
| Filed 2019-06-26 17:10 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Loinaz D'Isabella, Agustina Nathalia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2019-06-26 16:20 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2019-06-21 16:33 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$2,012,500
+1,250,000 vol $1.61 each |
1,250,000 | |
| Filed 2019-06-21 16:32 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-21 16:18 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Holder: Angstrom Capital Ltd. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$1,449,000
+900,000 vol $1.61 each |
900,000 | |
| Filed 2019-06-21 16:16 Tx date 2019-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Beck, Michael Paul
4 - Director of Issuer
Holder: Angstrom Capital Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-20 15:31 Tx date 2019-06-19 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,000
+20,000 vol $2.40 each |
1,020,000 | |
| Filed 2019-06-20 12:31 Tx date 2019-06-18 |
$KHRN
Khiron Life Sciences Corp. |
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-04-24 10:25 Tx date 2018-10-09 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$60,000
+50,000 vol $1.20 each |
548,000 | |
| Filed 2019-04-24 10:24 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$90,000
+75,000 vol $1.20 each |
498,000 | |
| Filed 2019-04-24 10:21 Tx date 2018-10-09 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-50,000 vol |
0 | |
| Filed 2019-04-24 10:20 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-75,000 vol |
50,000 | |
| Filed 2019-04-22 16:50 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-28 Tx date 2019-02-25 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$220,000
+100,000 vol $2.20 each |
1,431,889 | |
| Filed 2018-12-10 Tx date 2018-12-05 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,800
+10,000 vol $1.18 each |
719,500 | |
| Filed 2018-12-07 Tx date 2018-12-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,600
+15,000 vol $1.24 each |
1,331,889 | |
| Filed 2018-12-07 Tx date 2018-12-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,150
+5,000 vol $1.23 each |
1,316,889 | |
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+60,000 vol |
||
| Filed 2018-11-05 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+50,000 vol |
50,000 | |
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,600
+15,000 vol $1.64 each |
1,311,889 | |
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+60,000 vol |
||
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,728
-10,200 vol $1.64 each |
1,301,689 | |
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+75,000 vol |
125,000 | |
| Filed 2018-11-05 Tx date 2018-09-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,800
+112,000 vol $0.90 each |
423,000 | |
| Filed 2018-11-05 Tx date 2018-09-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$90,720
+100,800 vol $0.90 each |
||
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+90,000 vol |
||
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,280
-3,200 vol $1.65 each |
1,296,889 | |
| Filed 2018-11-05 Tx date 2018-09-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$90,720
+100,800 vol $0.90 each |
||
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+90,000 vol |
||
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,656
-1,600 vol $1.66 each |
1,300,089 | |
| Filed 2018-11-05 Tx date 2018-09-12 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$800,000
+888,889 vol $0.90 each |
1,311,889 | |
| Filed 2018-09-14 Tx date 2018-09-12 |
$KHRN
Khiron Life Sciences Corp. |
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$41,040
+45,600 vol $0.90 each |
947,450 | |
| Filed 2018-09-11 Tx date 2018-05-28 |
$KHRN
Khiron Life Sciences Corp. |
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,232,143 | ||
| Filed 2018-09-11 Tx date 2018-05-28 |
$KHRN
Khiron Life Sciences Corp. |
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-11 Tx date 2018-05-28 |
$KHRN
Khiron Life Sciences Corp. |
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-11 Tx date 2018-05-28 |
$KHRN
Khiron Life Sciences Corp. |
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-11 Tx date 2018-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+35,714 vol |
35,714 | |
| Filed 2018-09-11 Tx date 2018-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
|
Options
11 - Acquisition or disposition carried out privately
|
+200,000 vol |
200,000 | |
| Filed 2018-09-05 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,715 | ||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Holder: Dalvay Capital Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Holder: Dalvay Capital Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,850,000 | ||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,714 | ||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,715 | ||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
709,500 | ||
| Filed 2018-09-05 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-05 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-05 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-09-04 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-04 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,015,477 | ||
| Filed 2018-09-04 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,015,476 | ||
| Filed 2018-09-04 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-04 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,015,476 | ||
| Filed 2018-09-04 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,714 | ||
| Filed 2018-08-20 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,357 | ||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,357 | ||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,559,500 | ||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,975,322 | ||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
15,000 | ||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-08-20 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-08-20 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,975,322 | ||
| Filed 2018-08-16 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,975,322 | ||
| Filed 2018-08-16 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,357 | ||
| Filed 2018-08-16 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
51,758 | ||
| Filed 2018-08-16 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
119,045 | ||
| Filed 2018-08-16 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-08-15 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Simeon, Peter Emmanouil
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
310,000 | ||
| Filed 2018-08-15 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Simeon, Peter Emmanouil
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-07-23 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
281,000 | ||
| Filed 2018-07-23 Tx date 2018-07-17 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,481
+30,000 vol $1.08 each |
311,000 | |
| Filed 2018-07-20 Tx date 2018-07-17 |
$KHRN
Khiron Life Sciences Corp. |
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,725
+17,500 vol $1.07 each |
901,850 | |
| Filed 2018-05-31 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,046,429 | ||
| Filed 2018-05-31 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-05-31 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,715 | ||
| Filed 2018-05-31 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,200
+20,000 vol $1.11 each |
884,350 | |
| Filed 2018-05-31 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
864,350 | ||
| Filed 2018-05-31 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
107,143 | ||
| Filed 2018-05-31 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-05-28 Tx date 2018-05-28 |
$KHRN
Khiron Life Sciences Corp. |
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,321,430 |